相关实验视频
Updated: May 24, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.4K
KNU-DTI:Knowledge 联合 药物目标 相互作用 预测 预测
Ryong Heo1, Dahyeon Lee2, Byung Ju Kim3
1Interdisciplinary Graduate Program in Medical Bigdata Convergence, Kangwon National University, Chuncheon-si, 24341, Gangwon-do, Republic of Korea; UBLBio Corporation, Yeongtong-ro 237, Suwon, 16679, Gyeonggi-do, Republic of Korea.
Computers in biology and medicine
|March 2, 2025
概括
我们开发了KNU-DTI,这是一种新的药物向相互作用预测模型,优先考虑序列表示学习. 这种方法实现了高精度,优于竞争对手,并在药物发现中比对接模拟提供了优势.
科学领域:
- 计算化学是一种计算化学.
- 生物信息学是一种生物信息学.
- 药物发现 药物发现
背景情况:
- 准确的药物向蛋白相互作用 (DTI) 预测对于识别治疗化合物至关重要.
- 基于序列的模型提供了希望,但通常被复杂的算法所掩盖.
- 在DTI研究中,强大的序列表示学习被低估了.
研究的目的:
- 为了解决在DTI预测中对序列表示学习的忽视.
- 为了证明有效的特征提取可以导致使用更简单的算法准确的DTI模型.
- 通过优先考虑信息提取,推进实用和可通用的DTI预测框架.
主要方法:
- 开发了统一知识的DTI (KNU-DTI) 模型.
- 综合蛋白质结构性质 (使用结构性质序列 - SPS) 和分子特征 (使用扩展连接指纹 - ECFP).
- 使用神经网络从蛋白质和分子数据中提取了五个潜在向量,并将它们结合起来进行相互作用预测.
主要成果:
- 与最近的竞争对手相比,KNU-DTI模型在四个评估指标中表现出优异的表现.
- 一个案例研究表明,KNU-DTI在特定场景中比传统的对接模拟具有竞争优势.
- 该模型有效地利用序列和结构信息进行准确的DTI预测.
结论:
- 优先考虑强大的序列表示学习是开发准确的DTI预测模型的关键.
- KNU-DTI为现有的DTI预测方法提供了一种强大且潜在更有效的替代方案.
- 这项工作强调了特征提取在推进计算药物发现方面的重要性.
相关概念视频
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Drug-Receptor Interactions
4.8K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.8K
Drug-Receptor Interaction: Antagonist
2.6K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.6K
Combined Effects of Drugs: Antagonism
8.2K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.2K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Drug Discovery: Overview
7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K

